DUBLIN, Ireland--(BUSINESS WIRE)--Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European launch of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback